MYSM1 and melanoma: To at first analyze expression levels and distribution of MYSM1 in human melanocytes versus nevi and melanoma cells in situ, paraffin tissue sections of normal human skin and human melanoma samples were subjected to immunofluorescent (IF) staining against MYSM1 in combination with melanocyte marker Melan-A.